IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,317,196 | +8.3% | 1,548,826 | +1.2% | 0.01% | +14.3% |
| Q4 2023 | $7,680,138 | +196.2% | 1,529,908 | -0.3% | 0.01% | +133.3% |
| Q3 2023 | $2,592,692 | -8.3% | 1,534,137 | +50.9% | 0.00% | 0.0% |
| Q2 2023 | $2,825,854 | +74.5% | 1,016,494 | +14.3% | 0.00% | +50.0% |
| Q1 2023 | $1,619,253 | -53.7% | 889,699 | +29.0% | 0.00% | -50.0% |
| Q4 2022 | $3,496,951 | +0.8% | 689,734 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $3,469,000 | +35.5% | 698,052 | +1.4% | 0.00% | +33.3% |
| Q2 2022 | $2,561,000 | -0.2% | 688,474 | +50.5% | 0.00% | +50.0% |
| Q1 2022 | $2,566,000 | -2.0% | 457,475 | +6.2% | 0.00% | +100.0% |
| Q4 2021 | $2,619,000 | -31.3% | 430,754 | +10.0% | 0.00% | -50.0% |
| Q3 2021 | $3,815,000 | +50.1% | 391,661 | +120.0% | 0.00% | +100.0% |
| Q2 2021 | $2,542,000 | -41.2% | 178,025 | -2.2% | 0.00% | -50.0% |
| Q1 2021 | $4,323,000 | – | 182,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |